Related Experiment Video
Updated: Sep 15, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Bayesian network imputation methods applied to multi-omics data identify putative causal relationships in a type 2
Richard Howey1,2, Jonathan Adam3, Jerzy Adamski4,5,6
1Research Software Engineering, Newcastle University, Newcastle upon Tyne, United Kingdom.
Abstract:
Here we report the results from exploratory analysis using a Bayesian network approach of data originally derived from a large North European study of type 2 diabetes (T2D) conducted by the IMI DIRECT consortium. 3029 individuals (795 with T2D and 2234 without) within 7 different study centres provided data comprising genotypes, proteins, metabolites, gene expression measurements and many different clinical variables. The main aim of the current study was to demonstrate the utility of our previously developed method to fit Bayesian networks by performing exploratory analysis of this dataset to identify possible causal relationships between these variables. The data was analysed using the BayesNetty software package, which can handle mixed discrete/continuous data with missing values. The original dataset consisted of over 16,000 variables, which were filtered down to 260 variables for analysis. Even with this reduction, no individual had complete data for all variables, making it impossible to analyse using standard Bayesian network methodology. However, using the recently proposed novel imputation method implemented in BayesNetty we computed a large average Bayesian network from which we could infer possible associations and causal relationships between variables of interest. Our results confirmed many previous findings in connection with T2D, including possible mediating proteins and genes, some of which have not been widely reported. We also confirmed potential causal relationships with liver fat that were identified in an earlier study that used the IMI DIRECT dataset but was limited to a smaller subset of individuals and variables (namely individuals with complete data at pre-defined variables of interest). In addition to providing valuable confirmation, our analyses thus demonstrate a proof-of-principle of the utility of the method implemented within BayesNetty. The full final average Bayesian network generated from our analysis is freely available and can be easily interrogated further to address specific focussed scientific questions of interest.
Related Concept Videos
Causality in Epidemiology
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Genomics
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

